SUSMED,Inc. (TYO:4263)
Japan
· Delayed Price · Currency is JPY 1,149.00
+120.00 (11.66%)
Mar 10, 2026, 3:30 PM JST
SUSMED,Inc. Balance Sheet
Financials in millions JPY. Fiscal year is July - June.
Millions JPY. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 |
| Cash & Equivalents | 4,008 | 4,398 | 4,846 | 5,048 | 4,904 | 1,626 | Upgrade
|
| Cash & Short-Term Investments | 4,008 | 4,398 | 4,846 | 5,048 | 4,904 | 1,626 | Upgrade
|
| Cash Growth | -12.05% | -9.25% | -4.00% | 2.94% | 201.60% | 344.26% | Upgrade
|
| Accounts Receivable | 17 | 15 | 10 | 10 | 9 | 5 | Upgrade
|
| Other Receivables | 8 | - | 9 | - | - | 11 | Upgrade
|
| Receivables | 25 | 15 | 19 | 10 | 9 | 16 | Upgrade
|
| Prepaid Expenses | 63 | 47 | 30 | 25 | 21 | 26 | Upgrade
|
| Other Current Assets | 4 | 2 | 3 | 2 | 1 | 6 | Upgrade
|
| Total Current Assets | 4,100 | 4,462 | 4,898 | 5,085 | 4,935 | 1,674 | Upgrade
|
| Long-Term Investments | 106 | 24 | 25 | 8 | 8 | - | Upgrade
|
| Other Intangible Assets | 63 | 16 | 8 | 7 | - | - | Upgrade
|
| Other Long-Term Assets | 2 | - | 1 | 1 | - | - | Upgrade
|
| Total Assets | 4,271 | 4,502 | 4,932 | 5,101 | 4,943 | 1,674 | Upgrade
|
| Accounts Payable | - | 1 | - | - | - | - | Upgrade
|
| Accrued Expenses | 4 | 1 | 1 | 1 | 1 | - | Upgrade
|
| Current Income Taxes Payable | 67 | 71 | 67 | 82 | 70 | 81 | Upgrade
|
| Current Unearned Revenue | - | - | - | - | - | 6 | Upgrade
|
| Other Current Liabilities | 46 | 52 | 253 | 141 | 16 | 9 | Upgrade
|
| Total Current Liabilities | 117 | 125 | 321 | 224 | 87 | 96 | Upgrade
|
| Other Long-Term Liabilities | 1 | 7 | 7 | 7 | 6 | 1 | Upgrade
|
| Total Liabilities | 118 | 132 | 328 | 231 | 93 | 97 | Upgrade
|
| Common Stock | 117 | 99 | 80 | 40 | 1,853 | 100 | Upgrade
|
| Additional Paid-In Capital | 5,459 | 5,441 | 5,423 | 5,383 | 3,509 | 1,756 | Upgrade
|
| Retained Earnings | -1,491 | -1,218 | -920 | -562 | -511 | -278 | Upgrade
|
| Comprehensive Income & Other | 68 | 48 | 21 | 9 | -1 | -1 | Upgrade
|
| Shareholders' Equity | 4,153 | 4,370 | 4,604 | 4,870 | 4,850 | 1,577 | Upgrade
|
| Total Liabilities & Equity | 4,271 | 4,502 | 4,932 | 5,101 | 4,943 | 1,674 | Upgrade
|
| Net Cash (Debt) | 4,008 | 4,398 | 4,846 | 5,048 | 4,904 | 1,626 | Upgrade
|
| Net Cash Growth | -12.05% | -9.25% | -4.00% | 2.94% | 201.60% | 344.26% | Upgrade
|
| Net Cash Per Share | 238.26 | 261.90 | 290.30 | 307.76 | 333.99 | 127.09 | Upgrade
|
| Filing Date Shares Outstanding | 16.85 | 16.81 | 16.74 | 16.55 | 16.11 | 12.79 | Upgrade
|
| Total Common Shares Outstanding | 16.85 | 16.81 | 16.74 | 16.55 | 16.11 | 12.79 | Upgrade
|
| Working Capital | 3,983 | 4,337 | 4,577 | 4,861 | 4,848 | 1,578 | Upgrade
|
| Book Value Per Share | 246.42 | 259.94 | 275.06 | 294.25 | 301.11 | 123.26 | Upgrade
|
| Tangible Book Value | 4,090 | 4,354 | 4,596 | 4,863 | 4,850 | 1,577 | Upgrade
|
| Tangible Book Value Per Share | 242.68 | 258.98 | 274.58 | 293.83 | 301.11 | 123.26 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.